AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05022706 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Monthly Peer Support Groups
Description: The investigators will assign ALWH to a social support group with 9 to 11 other adolescents also participating in the research. The goal of the social support groups is to provide a venue for participants to share experiences and resources and provide encouragement and support to one another. Each group will last approximately 3 to 4 hours. Support groups will be led by adult peers or trained community health workers. The final group session will incorporate a discussion about the group experience, how it may change behavior, recommendations for improvement, and unmet needs that should be considered for a future intervention.
Study NCT04050228 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Quantitative ultrasound to guide adaptive chemotherapy
Description: Quantitative ultrasound results will be used to measure chemotherapy response and guide an adaptive chemotherapy strategy for patients who are found to be nonresponders to their chemotherapy.
Study NCT02995811 — intervention group
Intervention type: OTHER
Intervention: Observational Cohort
Description: Ultrasound assessment of 4 muscles, activity monitoring, daily global peripheral skeletal muscle strength
Study NCT02563886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrically Assisted Movement Therapy
Description: Electrically Assisted Movement Therapy (EAMT) is an extension of conventional Constraint-Induced Movement Therapy (CIMT) for moderately-to-severely paralyzed patients. During EAMT, patients use a movement controller with the healthy hand, controlling movements generated through neuromuscular electrical stimulation of the paralyzed arm and hand. During each session three types of exercises can be performed: mobilization, games, and training for activities of daily living, all three involving proper shaping of exercise difficulty at therapist discretion. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks.
Study NCT02563886 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electrically Assisted Movement Therapy
Description: Electrically Assisted Movement Therapy (EAMT) is an extension of conventional Constraint-Induced Movement Therapy (CIMT) for moderately-to-severely paralyzed patients. During EAMT, patients use a movement controller with the healthy hand, controlling movements generated through neuromuscular electrical stimulation of the paralyzed arm and hand. During each session three types of exercises can be performed: mobilization, games, and training for activities of daily living, all three involving proper shaping of exercise difficulty at therapist discretion. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks.
Study NCT02563886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual and customary care
Description: Usual and customary care ranges from no treatment to varying amounts of orthotics, home-based and clinic-based occupational therapy, or physiotherapy, but always excludes CIMT and EAMT. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks, whenever possible, to match EAMT amount of therapy.
Study NCT02563886 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual and customary care
Description: Usual and customary care ranges from no treatment to varying amounts of orthotics, home-based and clinic-based occupational therapy, or physiotherapy, but always excludes CIMT and EAMT. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks, whenever possible, to match EAMT amount of therapy.
Study NCT03035058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab
Description: Vedolizumab intravenous infusion
Study NCT03035058 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT03035058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT02633917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor control exercises
Description: exercises to strength the lumbar musculature and control the posture
Study NCT02633917 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard exercises
Description: general exercises
Study NCT04671745 — intervention group
Intervention type: BEHAVIORAL
Intervention: Music
Description: patient receiving care with interactive music
Study NCT04671745 — intervention group
Intervention type: BEHAVIORAL
Intervention: No music
Description: patient receiving care without interactive music
Study NCT03797794 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsating Electrostatic Field
Description: A pulsating electrostatic field is generated by the New Health 9000 (Akern). During the session the patients sits on a chair which contains the apparatus for 30 minutes.
Study NCT03797794 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM Pulsating Electrostatic Field
Description: The same apparatus which produces the pulsating electrostatic field contains a 'sham-inlet'. This inlet will be used as placebo.
Study NCT00317395 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: eptifibatide
Description: intravenous administration
Study NCT02788994 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endovis BA2 nail
Description: The EBA2 intramedullary nailing system is designed for the treatment of lateral proximal femoral fractures, and consists of a standard or medium length nail implantable with the same set of instruments.~The system has been designed to allow:~* stable fracture synthesis for fast rehabilitation and early mobilization~* an efficient set of instruments (only 11) for a swift, reproducible operating technique (just 7 surgical steps)
Study NCT03475355 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Live movement observation (Upper Limbs)
Description: All participants will be subjected to two 15-minute sessions per day of the Live movement observation of the upper limbs. The activities of the upper limbs will be based on some relevant activities of daily life such as drinking from a glass, combing, opening a box or eating an apple. The tasks will be both unimanual and bimanual.~Every day, before starting the physical training, the patient will be asked to look carefully at the therapist who shows 20 different daily routine activities (actions) performed with the upper limb.
Study NCT03475355 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Observation (Upper Limbs)
Description: All participants will be subjected to two 15-minute sessions per day of the video observation of upper limbs movements. The activities of the upper limbs will be based on some relevant activities of daily life such as drinking from a glass, combing, opening a box or eating an apple. The tasks will be both unimanual and bimanual.~Every day, before starting the physical training, the patient will be asked to carefully watch a video showing 20 different daily routine activities (actions) performed with the upper limb.
Study NCT03475355 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Live Movement Observation (Lowe Limbs)
Description: All participants will be subjected to two 15-minute sessions per day of the Live movement observation of the lower limbs. Tasks to avoid freezing will be based on strategies such as touching the thigh, taking side or back steps, counting out loud while walking.~Every day, before starting the physical training, the patient will be asked to carefully watch the therapist who will show 20 different movement strategies to avoid episodes of freezing the pace (FOG).
Study NCT03475355 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Observation (Lower Limbs)
Description: All participants will be subjected to two 15-minute sessions per day of the video observation of lower limbs movements. Tasks to avoid freezing will be based on strategies such as touching the thigh, taking side or back steps, counting out loud while walking. Every day, before starting the physical training, the patient will be asked to carefully watch a video that will show 20 different movement strategies to avoid episodes of freezing the pace (FOG).
Study NCT03475355 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Static Picture Observation and Upper Limbs Exercise
Description: Participants will watch for 3 minutes 5 static images that expose objects, none will represent animals or people.~The participant's attention will be kept high through a cognitive task. The patient will be presented a sequence of images for 3 minutes, the images will be displayed separately, each for 30 seconds, and then during the last 30 seconds, they will be displayed together with an intrusive image (intruder) that the patient you will be asked to identify so that your attention span can be controlled in real time. Participants will then be invited to perform limb movements as far as possible for 2 minutes according to a standard sequence involving joint mobilisations of upper limbs, and simulating that performed by the experimental groups.
Study NCT03475355 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Static Picture Observation and Lower Limbs Exercise
Description: Participants will watch for 3 minutes 5 static images that expose objects, none will represent animals or people.~The participant's attention will be kept high through a cognitive task. The patient will be presented a sequence of images for 3 minutes, the images will be displayed separately, each for 30 seconds, and then during the last 30 seconds, they will be displayed together with an intrusive image (intruder) that the patient you will be asked to identify so that your attention span can be controlled in real time. Participants will then be invited to perform limb movements as far as possible for 2 minutes according to a standard sequence involving joint mobilisations of lower limbs, and simulating that performed by the experimental groups.
Study NCT00842712 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: Cetuximab will be administered at a dose of 400 mg/m\^2 as intravenous infusion over 2 hours on Day 1 of Cycle 1 followed by 250 mg/m\^2 intravenous infusion over 1 hour once weekly on Days 8 and 15 of Cycle 1 and Days 1, 8, and 15 of all subsequent cycles until progressive disease, death, unacceptable toxicity, or consent withdrawal.
Study NCT00842712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Cetuximab will be administered at a dose of 400 mg/m\^2 as intravenous infusion over 2 hours on Day 1 of Cycle 1 followed by 250 mg/m\^2 intravenous infusion over 1 hour once weekly on Days 8 and 15 of Cycle 1 and Days 1, 8, and 15 of all subsequent cycles until progressive disease, death, unacceptable toxicity, or consent withdrawal.
Study NCT02788994 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Description: The DHS is designed to provide strong and stable internal fixation of a variety of intertrochanteric, subtrochanteric and basilar neck fractures, with minimal soft tissue irritation.~This Dynamic Hip Screw method is currently used and is a one off surgical fixation.
Study NCT01554267 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser-Assisted ICG Dye Angiography (SPY System)
Description: 7.5-10mg of ICG dye will be injected at 2 different time points during breast reconstruction with the assistance of the SPY system to determine areas of skin with poor blood flow. These areas are excised during the operation in order to decrease postoperative complications including mastectomy skin flap necrosis and reconstruction failure.
Study NCT01275859 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole, Lapatinib
Description: Letrozole 2.5mg po qd+ Lapatinib 1500mg po qd for 18-21 wks
Study NCT04503473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Stepping Training
Description: The goals will be to maximize stepping activity at high intensities for 40 minutes per 1 hour session, with rest breaks as needed~Conventional Therapy: : Participants provided conventional therapy will perform various standardized exercise tasks during 40 minutes of 1 hr sessions
Study NCT04503473 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: Participants provided conventional therapy will perform various standardized exercise tasks during 40 minutes of 1 hr sessions
Study NCT01894685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesalazine
Description: Mesalazine 3 grams, once daily for six months
Study NCT01894685 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 3 grams, once daily for six months
Study NCT01951326 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RHB-104
Description: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine
Study NCT02917213 — intervention group
Intervention type: OTHER
Intervention: Cardiac MRI
Description: A cardiac MR will be acquired a week and 6 months after enrollment. The protocol includes the following sequences: cine mode of short axes from LV base to apex, 2-3-4 chambers and STIR +T2 sequence. Perfusion during the administration of a bolus of 0.05 mmol / kg Gadovist®. 3D sequence of late enhancement of inversion-recovery. Images will be acquired after 10 min of the administration of a total of 0.2 mmol / g of Gadovist®. Intraventricular thrombosis will be monitored. Phase contrast sequences in three orthogonal planes will be acquired. Morphological parameters of LV function (LVEF), contractility (Wall Motion Score ), sphericity index, infarct size, area at risk, edema, microvascular obstruction and first-pass perfusion will be obtained.
Study NCT02917213 — intervention group
Intervention type: OTHER
Intervention: Brain MRI
Description: A brain MR will be acquired a week and 6 months after enrollment. Axial, sagittal and coronal spin echo sequence in T1, axial images in diffusion sequences (DWI), enhanced spin echo T2 and FLAIR (fluid-attenuated inversion recovery) sequences shall be obtained. A cerebral infarction will be positive when finding the presence of a focal lesion of> 3 mm in diameter that meets one of these three characteristics: (1) high signal on isotropic DWI images and low signal on the apparent coefficient map Broadcast (ADC). (2) Cavitary lesion hyperintense on T2, with no signal (or low) in the FLAIR sequence. (3) Hyperintense lesion T2 / T1 hypointense with prior distribution defect known or new in a follow-up study.
Study NCT01951326 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 5 placebo capsules administered orally BID
Study NCT04169542 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Natrum muriaticum 30C
Description: 3 globules of Natrum muriaticum applied once daily at days 7,8, and 9 after the start of the period.
Study NCT01934036 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Obex
Description: After concluded the two months of treatment, patients will be follow-up during three months without consumption of Obex.
Study NCT01934036 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: After concluded the two months of treatment, patients will be follow-up during three months without consumption of the placebo.
Study NCT00875706 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Educational Intervention
Description: The intervention consists of two (2) different types of training, both to be delivered through a train-the-trainer approach. The first of these is coaching-supervision training for nurse managers and other supervisory personnel in the CLC units. The second component is a one-day training for DCWs on communication and managing problem behaviors associated with dementia. These two trainings build on validated training models that have been developed by PHINational, but will be adapted and customized to include VA-developed clinical content on the management of problem behaviors associated with dementia.
Study NCT02917213 — intervention group
Intervention type: PROCEDURE
Intervention: Reveal LINQ insertable cardiac monitoring system
Description: A Reveal LINQ insertable cardiac monitoring system will be implanted following 1:1 patient unblinded randomization (device:no device). The device will be interrogated at a week after implantation and at 6 months, or if symptoms (palpitations or syncope) have activated the device memory.
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lachesis 30C
Description: 3 globules of Lachesis applied once daily at days 7,8, and 9 after the start of the period.
Study NCT03789357 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Aldosterone renin ratio
Description: Aldosterone Renin Ratio to screen for Primary Aldosteronism
Study NCT05113134 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transvaginal natural orifice specimen extraction (NOSE)
Description: Under general anesthesia, patients who are planned to perform multiport laparoscopic surgery for resection of solid organs including kidney, liver, stomach, adrenal gland and bladder will undergo Transvaginal NOSE
Study NCT05611385 — intervention group
Intervention type: OTHER
Intervention: Difference in development of Acute Lung Injury in Amphetamine positive and negative patients
Description: No Intervention
Study NCT00842712 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: Cis 80 mg/m\^2 intravenous infusion on Day 1 + Vin 25 mg/m\^2 or Cis 75 mg/m\^2 intravenous infusion on Day 1 + Gem 1250 mg/m\^2 intravenous infusion on Days 1 and 8 of each 3-week cycle will be administered along with Cil and cetuximab as per Investigator's discretion up to a maximum of 6 cycles.
Study NCT00842712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Cis 80 mg/m\^2 intravenous infusion on Day 1 + Vin 25 mg/m\^2 or Cis 75 mg/m\^2 intravenous infusion on Day 1 + Gem 1250 mg/m\^2 intravenous infusion on Days 1 and 8 of each 3-week cycle will be administered along with Cil and cetuximab as per Investigator's discretion up to a maximum of 6 cycles.
Study NCT04704167 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: fixation of double barrel vascularised fibula
Description: 3D titanium miniplate or 3D titanium mesh tray are used as a method of fixation for double barrel vascularized fibula
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sepia 30C
Description: 3 globules of Sepia applied once daily at days 7,8, and 9 after the start of the period.
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nux vomica 30C
Description: 3 globules of Nux vomica applied once daily at days 7,8, and 9 after the start of the period.
Study NCT04704167 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fixation of double barrel vascularised fibula
Description: 3D titanium miniplate or 3D titanium mesh tray are used as a method of fixation for double barrel vascularized fibula
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pulsatilla 30C
Description: 3 globules of Pulsatilla applied once daily at days 7,8, and 9 after the start of the period.
Study NCT02884674 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Repetitive Transcranial Magnetic Stimulation
Description: modulation of the electrical activity of the right inferior frontal gyrus cortex in order to reduce Obsessive Compulsive Disorders symptoms by Active Transcranial Magnetic Stimulation (TMS) targeting the right frontal inferior gyrus, 2 sessions per day, each session 5min30 day, during 10 consecutive days, using theta burst stimulation and using a TMS neuronavigated robot
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Folliculinum 30C
Description: 3 globules of Folliculinum applied once daily at days 7,8, and 9 after the start of the period.
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Natrum muriaticum
Description: 3 globules of placebo Natrum muriaticum applied once daily at days 7,8, and 9 after the start of the period.
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Lachesis
Description: 3 globules of placebo Lachesis applied once daily at days 7,8, and 9 after the start of the period.
Study NCT02402049 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Sepia
Description: 3 globules of placebo Sepia applied once daily at days 7,8, and 9 after the start of the period.
Study NCT02917213 — intervention group
Intervention type: OTHER
Intervention: Coagulation blood test
Description: 5 ml of peripheral blood will be obtained for assessment of prothrombotic markers at enrollment, at one week and 6 months after enrollment.
Study NCT02917213 — intervention group
Intervention type: OTHER
Intervention: Transcranial Doppler monitoring
Description: A Transcranial Doppler monitoring will be performed in the first 24 hours after enrollment in order to detect High Intensity Transient Signals (HITs).
Study NCT02884674 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Repetitive Transcranial Magnetic Stimulation
Description: Sham rTMS will be delivered using non active magnetic coil, targeting the right frontal inferior gyrus, 2 sessions per day, each session 5min30 day, during 10 consecutive days, using TMS neuronavigated robot. A subjective sensation will be obtained via frontal dermic electrical stimulation.
Study NCT03551977 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iCanCope with Pain
Description: The participants are free to use the Norwegian iCanCope with Pain app as much as they want during the 8 week intervention period. The only support available is technical support.
Study NCT03551977 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: iCanCope with Pain control
Description: The participants are free to use the Norwegian iCanCope with Pain control app as much as they want during the 8 week intervention period. The only support available is technical support.